Post No. 2,657 The following is brought to you by Intellivest Securities Research, Inc. Toward the end of this Blog is a list of the Dow 30 current CEOs, and a recent ranking of the Dow 30 components by market capitalization and a summary of recent Dow 30 components' SEC filings.
A read of the print editions of Tuesday's Wall St. Journal, Financial Times, Investor's Business Daily, New York Times, USA Today, Atlanta Journal & Constitution & Daily Report (Ga. -carries Bloomberg) yielded the following stories about Dow Jones Industrial Average 30 component companies and the Dow with stories about the Dow aggregated first and then items about Dow Jones Industrial Average 30 companies presented alphabetically, followed by a separate table of Dow component's symbol and Monday's closing stock prices and related data in alphabetical order.
The Dow Jones Industrial Average: The Dow Jones Industrial Average closed Monday at 16530.55 up 17.66 or 0.11% from Friday's close of 16512.89. For the year the Dow is down 0.92%. Of the Dow components 17 gained and 13 declined. The biggest gainer dollar-wise was Visa up $2.53 and percentage-wise was Boeing up 1.55%. The biggest decliner dollar-wise was Goldman Sachs down $2.53 and percentage-wise was JPMorgan down 2.45 %.
As of the open the market on Tuesday the current divisor for the Dow Jones Industrial Average found at page C5 of Tuesday's Wall St. Journal is 0.15571590501117. Tuesday's trailing P/E ratio is 16.12 up from Monday's trailing P/E ratio of 16.11 (last year it was 16.38). Tuesday's P/E estimate is 14.81 unchanged from Monday's P/E estimate of 14.81 (year ago it was 13.25) and Tuesday's dividend yield is 2.41 up from Monday's dividend yield of 2.16 (last year it was 2.39). The Dow's all-time high was 16,580.84 on April 30, 2014. The 12 year low close for the Dow was on March 9, 2009 when it fell to 6,547.05.
WSJ pC4 "Stocks edge higher as tech leads the way" by Dan Strumpf says US stocks recovered from a morning slide to end higher due to disappointing news from Pfizer and JPMorgan and a mixed bag of economic data from China and the US.
NYT pB8 "Shares advance only narrowly after concerns from abroad" & AJC pA9 "Indexes reverse early losses" by AP says the stock market closed slightly higher due to improving US service sector and less concern re: China.
IBD pB2 "Stocks end well off lows, but turnover disappoints" by Ken shreve says MOnday's action saw positive reversal in lower vol due to weak manufacturing data in China and Ukraine clashes. the current outlook is market is in correction.
Monday's Dow Jones Industrial Average closing numerator was 2574.07 up 2.75 from Friday's closing numerator of 2571.32. This is the sum of all 30 closing prices. A short cut to the Dow numerator is to multiply the closing Dow by the Divisor. Now, if you divide the Dow numerator change for today by the divisor (0.15571590501117) you get the change in today's Dow. A dollar increase or decrease in a Dow stock results in a $6.42 change in the Dow Index.
The average closing price (the closing numerator divided by 30) of Monday's Dow Jones Industrial Average was $85.80 up 9 cents from Friday's average closing price of $85.71. The median closing price of Monday's Dow Jones Industrial Average was $79.96 (HD/DIS) up 11 cents from Friday's closing median price of $79.85 (HD/DIS). The lowest volume was IBM and the highest volume was Pfizer.
If Monday morning before the market opened you had purchased 100 shares of each of the Dow Jones Industrial Average 30 shares (assuming you could buy fractional shares and assuming no transaction costs or dividends) and sold at the close you would have made $275 ($257,407 - $257,132).
5/5/14 Monday 4:06 pm MarketWatch by Anora Mahmudova says U.S. stocks closed higher on Monday, as investors shrugged off earlier worries over the slowing economy in China and deteriorating situation in Ukraine. Better-than-expected data on the U.S. services sector aided markets. The S&P 500 SPX +0.19% ended the day 3.51 points, or 0.2%, higher at 1,884.65, trading near record levels. Utilities and health-care sector stocks led the gains. The Dow Jones Industrial AverageDJIA +0.11% turned a more-than 100-point-loss to a gain of 17.66 points, or 0.1% to 16,530.55. The Nasdaq Composite COMP +0.34% finished the day 14.16 points, or 0.3%, higher at 4,138.06.
Tuesday's Dow News followed by Monday's Closing Dow Numbers:
AT&T: WSJ pB1 "Media deals: power, money, promise" by Ryan Knutson, Thomas Gryta, Brent Kendall says AT&T & Verizon are moving toward a future where wireless service, video and the Internet will be offered in one convenient package.
American Express: No mentions found.
Boeing: No mentions found.
Caterpillar: WSJ pC3 "Caterpillar sells 50 year bonds" by Mike Cherney, Vipal MOnga says caterpillar sold 50 year bonds taking advantage of investors demand for interest rates that are low. The $500 mil of bonds yielded 1.3% better than US treasurys.
Chevron: No mentions found.
Cisco: No mentions found.
Coke: NYT pB6 "Coca-Cola to remove an ingredient questioned by consumers" by Stephanie Strom, AJC pA7 "Coke, Pepsi to drop dispute ingredient" by Candice Choi AP, UsAT p2B "Coke, Pepsi to drop BVO from drinks" by AP say Coke will remove brominated vegetable oil from its drinks.
AJC pA7 "Buffett: Coke can easily trim pay plan" by AP says Buffett didn't vote against the pay plan but he got his message to the CEO.
Disney: No mentions found.
DuPont: No mentions found.
ExxonMobil: No mentions found.
GE: WSJ pB1 "France threatens to block GE deal" by Ted Mann, Inti Landauro, NYT pB6 "French government opposes GE deal for Alstom's electricity units" by David Jolly say the French gov wants GE to alter the terms of its $17 bil takeover of Alstom's energy assets.
Goldman Sachs: WSJ pC8 "JPMorgan shivers, Wall St gets a cold" by John carney says JPMorgan warned Fri to expect 2Q trading rev to be down 205 from a year ago. In '13 it got 16% from its annual rev from fixed income, currency and commodities trading while Goldman Sachs got 25%.
Home Depot: No mentions found.
Intel: IBD pA4 "Computer tech maker serves up a winning business model" by Vance Cariaga says Intel typically introduces a new CPU architecture every year, then introduces an upgrade 6 months later.
IBM: IBD pA2 "Tableau software bangs table, says its growth story is intact" by Pete Parlas says Tableau Software is growing at the expense of IBM and SAP.
JPMorgan: WSJ pC8 "JPMorgan shivers, Wall St gets a cold" by John Carney, WSJ pC1 "Banks' profit engine still sputters" by Justin Baer, Saabira Chaudhuri, IBD pA1 "JPMorgan warning sign of new normal for Wall St banks" by Ciaran McEvoy say JPMorgan warned Fri to expect 2Q trading rev to be down 205 from a year ago. In '13 it got 16% from its annual rev from fixed income, currency and commodities trading while Goldman Sachs got 25%.
WSJ pC4 "Stocks edge higher as tech leads the way" by Dan Strumpf says US stocks recovered from a morning slide to end higher due to disappointing news from Pfizer and JPMorgan and a mixed bag of economic data from China and the US.
NYT pB2 "Madoff trustee pays out $351 mil to Ponzi victims" by Reuters, IBD pA2 "Benrad Madoff's Ponzi" say most of this money is from a settlement with JPMorgan, which had been Madoff's main bank for more than 2 decades.
Johnson & Johnson: No mentions found.
McDonald's: No mentions found.
Merck: WSJ pD1 "The research race to make drugs more efficient" by Shirley S. Wang says Pfizer & Merck are among drug makes that use polyethene glycol to keep drugs effective longer.
Microsoft: No mentions found.
Nike: WSJ pB6 "Adida moves toward Rockport sale" by Dana Mattioli, Sara Germano says Adidas has lost global traction from Nike which has been posting consistent growth on Adidas's home turf in W. Europe with sales of $1.3 bil for the recent quarter there.
fT p15 "Wearables industry ponders next step after Nikehalts fitness band" by Tim Bradshaw, Sarah Mishkin says Nike's decision to stop developing its FuelBand fitness tracking bracelet last month sent shockwaves through the wearables industry.
Pfizer: IBD pA5 "Drug giant Pfizer misses ons ales, beats on EPS, affirms guidance" by Amy Reeves, NYT pB3 "Profits off, Pfizer again aims to lure AstraZeneca" by Katie Thomas, AJC pA8 "Pfizer 1Q profit drops 15% due to lower sales", WSJ pB3 "Pfizer weighs options as it still pursues AstraZeneca" by Jonathan D. Rockoff , FT p10 "Pfizer/AstraZeneca, FT p7 "Ownership is irrelevant in the global pharma race" by Richard Sykes, fT p1 "Cameron warned over Pfizer support" by George Parker, Andrew Ward, FT p14 "Drugs pipeline under microscope" by Andrew Ward, FT p14 "If the price right, then money does the talking" by Ed Hammond, USA Today p6B "A bitter pill: lower sales hurt Pfizer profit" by Kevin McCoy say 1Q net income was $2.33 bil or 36 cents per share down from 42.75 bil or 38 cents a share a year earlier. Rev totaled $11.35 bil down 9%. Pfizer confirmed its '14 profit forecast for eps of $2.20 to $2.30 & rev of $49.2 bil to $52.3 bil.
WSJ pD1 "The research race to make drugs more efficient" by Shirley S. Wang says Pfizer & Merck are among drug makes that use polyethene glycol to keep drugs effective longer.
WSJ pC4 "Stocks edge higher as tech leads the way" by Dan Strumpf says US stocks recovered from a morning slide to end higher due to disappointing news from Pfizer and JPMorgan and a mixed bag of economic data from China and the US. Pfizer is charted under Bad News.
Procter & Gamble: No mentions found.
3M: No mentions found.
Travelers: No mentions found.
United Technologies: No mentions found.
UnitedHealth: No mentions found.
Verizon: WSJ pB1 "Media deals: power, money, promise" by Ryan Knutson, Thomas Gryta, Brent Kendall says AT&T & Verizon are moving toward a future where wireless service, video and the Internet will be offered in one convenient package.
Visa: No mentions found.
Walmart: WSJ pB2 "Walmart notches web win" by Shelly banjo says for the first time in a decade walmart's web sales grew faster than Amazons.
Monday's Closing Dow Numbers:
| Symbol | Last Sale | Change | % Change | Share Volume | Market |
|---|---|---|---|---|---|
| T | ▲ | NYSE | |||
| AXP | ▲ | NYSE | |||
| BA | ▲ | NYSE | |||
| CAT | ▼ | NYSE | |||
| CVX | ▲ | NYSE | |||
| CSCO | ▲ | NASDAQ-GS | |||
| KO | ▼ | NYSE | |||
| DIS | ▲ | NYSE | |||
| DD | ▲ | NYSE | |||
| XOM | ▲ | NYSE | |||
| GE | ▼ | NYSE | |||
| GS | ▼ | NYSE | |||
| HD | ▼ | NYSE | |||
| INTC | ▼ | NASDAQ-GS | |||
| IBM | ▼ | NYSE | |||
| JPM | ▼ | NYSE | |||
| JNJ | ▲ | NYSE | |||
| MCD | ▼ | NYSE | |||
| MRK | ▲ | NYSE | |||
| MSFT | ▼ | NASDAQ-GS | |||
| NKE | ▲ | NYSE | |||
| PFE | ▼ | NYSE | |||
| PG | ▼ | NYSE | |||
| MMM | ▲ | NYSE | |||
| TRV | ▼ | NYSE | |||
| UTX | ▲ | NYSE | |||
| UNH | ▲ | NYSE | |||
| VZ | ▲ | DualListed | |||
| V | ▲ | NYSE | |||
| WMT | ▼ | NYSE |
*****************
Here are the current CEOs of the Dow 30 Companies:
AT&T T Randall L. Stephenson (Dallas, TX)
American Express AXP Kenneth I. Chenault (NY, NY)
Boeing BA W. James McNerney, Jr. (Chicago, Ill)
Caterpillar CAT Douglas Oberhelman (Peoria, Ill.)
Chevron CVX John Watson (San Ramon, CA)
Cisco CSCO John Chambers (San Jose, CA)
Coca Cola KO Muhtar Kent (Atlanta, GA)
Disney DIS Robert Iger (Burbank, CA)
DuPont DD Ellen Kullman (Wilmington, DE)
ExxonMobil XOM Rex W. Tillerson (Irving, Tx)
GE Jeffrey R. Immelt (Fairfield, CT)
Goldman Sachs GS Lloyd Blankfein (NY, NY)
Home Depot HD Frank Blake (Atlanta, GA)
Intel INTC Brian Krzanich (Santa Clara, CA)
IBM Virginia M. Rometty (Armonk, NY)
JPMorgan Chase JPM Jamie Dimon (NY, NY)
Johnson & Johnson JNJ Alex Gorsky (New Brunswick, NJ)
McDonald's MCD Donald Thompson (Oak Brook, Ill)
Merck MRK Kenneth Frazier (Whitehouse Station, N.J.)
Microsoft MSFT Satya Nadella (Redmond, WA)
Nike NK Mark Parker (Beaverton, OR)
Pfizer PFE Ian Read (NY, NY)
Procter & Gamble PG A. G. Lafley (Cincinnati, OH)
3M MMM Inge Thulin (St. Paul, MN)
Travelers TRV Jay S. Fishman (NY, NY)
UnitedHealthUNC Stephen Hemsley (Minnetonka, MN)
United Technologies UTX Louis Chenevert (Hartford, CT)
Verizon VZ Lowell McAdam (NY, NY)
Visa V Charles W. Scharf (Foster City, CA)
Wal-Mart WMT Doug McMillon (Bentonville, ARK)
***************************
Here are the Dow Jones Industrial Average 30 as of 4/17/14 ranked in order of market capitalization in billions:
1. Exxon Mobil XOM $433.94
2. Microsoft MSFT 332.11
3. Johnson & Johnson JNJ 279.95
4. GE 266.48
5. WalMart WMT 250.78
6. Chevron CVX 236.12
7. Procter & Gamble PG 221.68
8. JPMorgan Chase JPM 209.13
9. IBM 197.87
10. Verizon VZ 197.
11. Pfizer PFE 193.08
12. AT&T T 187.65
13. Coke KO 179.41
14. Merck MRK 166.06
15. Disney DIS 140.15
16. Intel INTC 134.44
17. Visa V 131.76
18. Cisco CSCO 119.56
19. United Technologies UTX 108.52
20. Home Depot HD 106.49
21. McDonald's MCD 99.24
22. Boeing BA 95.1
23. American Express AXP 91.44
24. 3M MMM 91.27
25. UnitedHealth UNH 74.96
26. Goldman Sachs GS 73.58
27. Caterpillar CAT 65.59
28. Nike NKE 65.016
29. DuPont DD 62.14
30. Travelers TRV 30.54
****************************************
Here are the latest 8K, 10Q & 10K & Proxy & certain other SEC filings as of 4/17/14:
Symbol & Co. Name/Date of Filing/Form Filed/ Comments
AT&T T:
3/31/14 8K re: closing of sale of Flotating Rate Global Notes due '17
3/14/14 8K re: issuance of Notes to purchase LEAP
3/11/14 Proxy re Annual Meeting of Stockholders, 4/25/14 9 am, Rivermill Event Centre, Columbus, GA
3/10/14 8K re: issuance of Global Notes
2/21/14 10K for year ended 12/31/13
1/29/14 & 1/28/14 8Ks re: 4Q earnings release
1/22/14 8K re: certain fin'l items for 4Q
American Express AXP:
4/16/14 8K re: 1Q results
4/15 8K re: delinq. & write-off stats for 3 months ended 3/31/14
3/27/14 Proxy re: Annual Mtg. of Shareholders 5/12 at 9 a.m. at AXP HQ in NYC
3/26/14 8K re: dividend of 26 cents per share & buyback of up to $4.4 bil of common shares in '14
3/17/14 8K re: jv agreement with Certares re: Global Business Travel Division
3/17/14 8K re: delinq. & write-off stats for 3 months ended 2/28/14
2/25/14 10K for year ended 12/31/13
2/18/14 8K re: delinq. & write-off stats for 3 months ended 1/31/14
1/16/14 8K re: 4Q results
1/15/14 8K re: deling. & write-off states for 3 mos. through 12/31/13
Boeing BA:
3/14/14 Proxy for Annual Meeting of Shareholders 4/28/14 10:00 am, Field Museum, Chicago
3/11/14 8K re: amendments to Supp. Exec. Retirement Plan
4/28/14 8K re: selection of Robert E. Verbeck as VP Finance
2/27/14 8K re: grants of restricted stock units to execs
2/14/14 10K for year ended 12/31/13
1/29/14 8K re: 4Q results
Caterpillar CAT:
3/20/14 8K re: 3 month dealer stats thru 2/14
2/20/14 8K re: retail sales info
2/18/14 10K for year ended 12/31/13
1/27/14 8K re: 4Q results & 12/31/13 results
1/24/14 8K re: 3 mo. dealer stats thru 12/13
Chevron CVX:
4/10/14 Proxy re: Annual Meeting of Shareholders on 5/28 at Permian Basin Petroleum Museum, Midland, Tx at 8 am
4/9/14 8K re: Interim update for 1Q
3/28/14 8K re: increase in comp. to exec officers
2/21/14 10K for year ended 12/31/13
1/31/14 8K re: grants of stock options to execs
1/31/14 8K re: 4Q and year end results
1/9/14 8K re: interim update for 4Q
Cisco CSCO:
3/26/14 8K re: adoption of pre-arranged exec stock trading plans
3/11/14 8K re: exec's pre-arranged stock trading plan
3/3/14 8K re: issuance of Floating Rate Notes
2/26/14 8K re: public offering of Senior Notes
2/20/14 10Q & 2/12/14 8K re: qtr. ended 1/25/14
Coke KO:
4/15/14 8K re: 1Q results
4/3/14 & 3/28/14 Proxy material re: issue of exec. comp.
3/7/14 8K re: public offering of $1 bil Floating Rate Notes due '15
3/7/14 Proxy Statement re: Shareholder Meeting 4/23/14 12:30 pm Cobb Galeria, Atlanta
2/27/14 10K for year ended 12/31/13
2/21/14 8K re: Kathy Walker replacing Gary Fayad as EVP/CFO & retirement from BoD of Donald F. McHenry & Jacob Wallenberg
2/19/14 8K re: amendment of Restricted Stock Award Plan
2/18/14 8K re: results of 4Q & year
2/6/14 8K re: agreement with Green Mt. Coffee Roaster
1/24/14 8K & 12/18/13 8K both re: departure of EVP & Pres. of Coca-Cola Americas Steven A. Cahillane
Disney DIS:
3/20/14 8K re: amdmt to cert. of incorp.
3/18/14; 3/4/14; & 2/3/14 Add'l proxy materials
2/5/14 10Q & 2/5/14 8K re: Qtr ended 12/28/13
1/24/14 Def. Proxy (& Prelim 12/23/13) re: Annual Shareholders Mtg on 3/18/14 at 10 am Keller Aud., Portland, OR
DuPont DD:
/17/14 8K re: results for qtr ended 3/31
3/14/14 Proxy Stockholders Mtg 4/23/14 10:30 am, DuPont Theatre, Wilmington, DE
3/10/14 8K re: guidance for 2014
2/5/14 10K for year ended 12/31/13
1/28/14 8K re: 4Q results
ExxonMobil XOM:
4/11/14 Proxy re: Shareholder Mtg on 5/28 at Myerson Symphony Ctr, Dallas, Tx at 9:30 am
3/24/14 8K re: Reg. FD disclosure re: '13 Fin'l & Operating Rev
3/20/14 8K re: issuance of Float Rate Notes
3/11/14 8K re: presentation at analyst meeting
2/26/14 10K for year ended 12/31/13
2/21/14 8K re: oil reserves info
1/30/14 8K re: 4Q results
GE:
4/17/14 8K re: 1Q results
3/11/14 8K re: public offering of Notes
3/5/14 Proxy Annual Shareholders Meeting 4/23/14 10 am Sheraton, Chicago
2/27/14 10K for year ended 12/31/13
1/17/14 8K re: 4Q results
Goldman Sachs GS:
4/17/14 8K re: 1Q results
4/4/14 Proxy re: Shareholder Mtg at 5/16 at GS Office, Irving Tx at 9:30 am
3/26/14 8K re: revised '14 capital plan submitted to Fed. Res. Bd.
3/3/14 8K re: issuance of Notes
3/3/14 8K re: election of Peter Oppenheimer to Bod
2/28/14 10K for year ended 12/31/13
2/12/14 8K re: public offering of debt
1/16/14 8K re: 4Q & year end results for 12/31/13.
Home Depot HD:
4/7/14 Proxy re: Shareholder Mtg 5/22 Cobb Galleria Centre, Atlanta, Ga. at 9:00 am
3/27/14 10K for year ended 2/2/14
2/28/14 8K re: election of Craig A. Menear, Pes. US Retail
2/25/14 8K re: results for fiscal year and qtr ended 2/2/14
Intel INTC:
4/15/14 8K re: 1Q results
4/7/14 8K re: changes to operating segments reports
4/3/14 Proxy re: Stockholder Mtg on 5/22 at 8:30 am at Intel HQ, Santa Clara, CA
2/14/14 10K for year ended 2/28/13
2/3/14 8K re: comp structure for execs & employees
1/16/14 8K re: results for 4Qtr & fiscal year ended 12/28/13
IBM:
4/17/14 & 4/16/14 8K re: 1Q earnings presentation
4/3/14 Proxy re: add't'l info
3/10/14 Proxy Stockholder Mtg 4/29/14 10 am Osborn Conv. Ctr., Jacksonville, FL
2/25/14 8K 10K for year ended 12/31/13
2/11/14 8K re: public offering of debt
2/10/14 8K re: closing of sale of IBM's customer care process outsourcing business to SYNNEX
1/31/14 8K re: exec comp. structure
1/23/14 8K re: sale of x86 server portfolio to Lenovo
1/22/14 8K re: 4Q earnings presentation
JPMorganChase JPM:
4/11/14 2 8Ks re: 1Q results
4/9/14 Proxy re: Shareholder Mtg at JPM Offices on 5/20/14 at Tampa, Fl at 10:00 am
3/26/14 8K re: dividend of 40 cents per share & buyback of $6.5 bil of common stock
3/20/14 8K results of '14 Dodd-Frank Act Stress Tests
3/14/14 8K re: issuance of Notes
3/10/14 8K re: issuance of Pref. Stock
3/5/14 8K re: issuance of Notes
2/27/14 8K re: Investor Day Presentation
2/6/14 8K re: sale of Pref. Stock
2/5/14 8K re: payment of $614 mil to settle mortgage case brought by US Atty SDNY, FHA, HUD & VA
1/30/14 8K sale of Pref. Stock
1/28/14 8K re: public offering of Notes
1/24/14 8K re: grant of restricted stock units to CEO Jamie Dimon
1/22/14 8K re: issuance of fixed to floating rate non-cumulative preferred stock
1/14/14 2 8Ks re: 4Q results
1/7/14 8K re: settlement with various regulations relating to Madoff fraud
1/3/14 8K re: election of Michael A. Nead to Board
Johnson & Johnson JNJ:
4/15/14 8K re: results of 1Q ended 3/30/14
3/12/14 Proxy - Shareholder Meeting 4/24 10 am Hyatt Regency, New Brunswick, NJ
2/21/14 10K for year ended 12/29/13
1/21/14 8K re: 4Q 7 fiscal year ended 12/29/13 results
1/17/14 8K re: sale to Carlyle Group of Ortho-Clinical Diagnostics unit
McDonald's MCD:
4/11/14 Proxy re: Shareholder Mtg on 5/22/14 at 8 am at MCD HQ at Oak Brook, Ill
3/21/14 8K re: retirement of COO Tim Fenton & global mgmt. restructure
3/13/14 8K re: presentation at Merrill Lynch Consumer Retail Conf. in NYC 3/12
3/10/14 8K re: Feb. sales
2/24/14 10K for year ended 12/31/13
2/14/14 8K re: exec awards under cash performance unit plan
2/10/14 8K re: Jan sales
1/31/14 8K re: payout structure for '14 Target Incentive Plan for Execs
1/23/14 8K re: 4Q & full year results for period ended 12/31/13
Merck MRK:
4/14/14 Proxy re: Shareholder Mtg on 5/27 at 9 am at Bridgewater Marriott, Bridgewater, NJ
3/27/14 8K re: departure of EVP/CEO Peter N. Kellogg
2/28/14 8K re: amdmt of Bylaws so 15% of shareholders can call a meeting
2/27/14 10K for year ended 12/31/13
2/5/14 8K re: retirement of John Canan, Sr. VP Finance
2/5/14 8K re: 4Q & full year results
Microsoft MSFT:
3/20/14 8K re: resignation from Bd. of Dirs. of Stephen J. Luczo
3/12/14 8K re: election of G. Mason Morfit, Pres. ValueAct Capital, to BoD
2/4/14 8K re: election of Satya Nadella as CEO
1/23/14 10Q & 1/23/14 8K re: 4Q ended 12/31/13
Nike NKE:
4/7/14 10Q & 3/25/14 & 3/20/14 8Ks re: Year ended 2/28/14
1/7/1410Q & 12/23/14 8K & 12/19/13 8K re: 4Q ended 11/30/13
Pfizer PFE:
4/11/14 & 4/2/14 Proxy re: add't'l info
3/13/14 Proxy - Shareholder Meeting 4/24/14 8:30 am Hilton Short Hills, NJ
2/28/14 10K for year ended 12/31/13
1/28/14 8K re: results for 4Q and year
Procter & Gamble PG:
4/9/14 8K re: sale of Pet Food biz to Mars for $2.9 bil
4/7/14 8K re: dividend of 64 cents on common & preferred shares
2/28/14 8K re: A.G. Lafley's pre-arranged stock trading plan
2/14/14 8K re: exercise of stock options by CEO A.G. Lafley
2/11/14 8K re: company guidance
1/24/14 10Q & 1/24/14 2 8Ks re: results for fiscal year ended 12/31/13
1/14/14 8K re: declaration of quarterly dividend
3M MMM:
4/15/14; 3/27/14; & 3/26/14 Proxy re: Stockholder Mtg on 5/13/14 at 10:00 am at Austin Conv. Ctr. at Austin, Tx
4/8/14 8K re: imminent danger order issued and then lifted for Greystone Plant at Wauscu, Wisc.
3/5/14 8K re: realignment of business segments
2/13/14 10K for year ended 12/31/13
1/30/14 8K re: 4Q & full year results
Travelers TRV:
4/11/14 Proxy re: shareholder Mtg on 5/27 at 1 pm at Hartford Marriott Downtown, Hartford, Ct.
3/17/14 8K re: cahnge of date of Annual Shareholders Meeting from 5/28 to 5/27/14 at Hartford, Ct., Mariott Downtown
2/13/14 10K for year ended 12/31/13
2/6/14 8K re: election of Philip T. Ruegger III to Bod
1/21/14 8K re: 4Q results ended 12/31/13
United Technologies UTX:
4/8/14 Proxy re: add'l info
3/14/14 Proxy - Shareholder Meeting 4/28 2 pm Ritz-Carlton, Charlotte, NC
2/6/14 10K for year ended 12/31/13
1/22/14 8K re: 4Q results
UnitedHealth Group UNH:
4/17/14 8K re: 1Q results
3/7/14 8K re: presentation at Barclays Global Healthcare Conf. Miami 3/11
2/28/14 8K re: presentation at Raymond James INv. Conf. Orlando 3/4
2/12/14 10K for year ended 12/31/13
1/16/14 8K re: 4Q & full year results
1/3/14 8K re: presentation at Goldman Sachs Healthcare Conf.
Verizon Communications Inc. VZ:
4/11/14 Proxy re: add'l info
3/17/14 Proxy - Annual Meeting of Shareholders 5/1/14 10:30 am, Sheraton, Phoenix, AZ
3/10/14; 2/1/14; 1/30/14 & 1/28/14 8Ks re: closing of the purchase of Vodafone's 45% interest in Verizon Wireless
3/7/14 8K re: declaration of quarterly dividend & repurchase program of up to 100 mil shares
2/27/14 10K for year ended 12/31/13
2/24/14 8K re: 2014 guidance
2/12/14 8K re: closing of sale of Notes
2/11/14 8K re: exec comp.
1/21/14 8K re: 4Q results
Visa V:
3/1/314 8K re: resignation of Elizabeth Buse, EVP Solutions
3/7/14 8K re: pre-arranged stock trading plan for CFO
3/5/14 8K re: presentation at Morgan Stanley tech, Media & Telecom Conf 3/5
1/30/14 10Q for qtr ended 12/31/13
1/29/14 8K re: results of 1/29/14 Annual Meeting of Stockholders
1/29/14 8K re: declaration of dividends
WalMart WMT:
4/7 8K re: issuance of euro Notes due '22
3/21/14 10K for FY ended 1/31/14
2/20/14 8K re: 4Q results
2/13/14 8K re: amendment to bylaws to allow 10% of sharehodlers to call a meeting
1/31/14 8K re: 2014 guidance
1/29/14 8K re: election of C. Douglas McMillan as Pres/CEO
1/29/14 8K/A re: compensation for EVP David Cheesewright
SO LONG, THAT'S ALL
No comments:
Post a Comment